Boots' Symptoms Claim For Dual Defence Not A Prevention Pitch – UK Regulator
Executive Summary
Boots UK’s display ad for its Dual Defense cold and flu symptom nasal spray was unlikely to deceive consumers to think it could prevent infection, UK Advertising Standards Authority says, which found that text in a poster ad sufficiently "conceptualized" the claim.
You may also be interested in...
Cold Sore Ad Claims Review Poses Test For OTC Monograph Indications
Council of Better Business Bureaus forwards review of ad claims for Aubio Life Sciences' monograph cold sore treatment to US FDA and FTC, after firm rejected advice to discontinue certain claims. Initial challenge was brought by GSK, which markets an NDA cold sore product.
Carmex Cold Sore Treatment Claims Exceed Monograph Limit In NAD Review
Carma Labs’ Carmex Cold Sore Treatment claims did not mirror language in two OTC monographs for its active ingredients, the National Advertising Division says in a review of packaging and advertising claims challenged by GlaxoSmithKline's consumer business.
Industry Roundup: Inaffit Recall, UK Cold/Flu Claim Canned, Earth’s Best Repackaged
Boots ‘cold and flu’ claim booted in UK; $16M financing for JDS, Nutrition 21; Neon Energy sponsors Idol winner’s tour; New Global makes ISG’s MoringaUP bars; and more news in brief.